Detailansicht

Wissensnetz

Person

Felix Mottaghy (1970-)

Arzt

Name	Felix Mottaghy
Zeit	1970- (Lebensdaten)
Ort	München (Geburtsort) Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Prof. Dr. med.
Beruf	Arzt (charakteristischer Beruf) Nuklearmediziner Hochschullehrer
Variante	Felix Manuel Mottaghy (vollständiger Name) F. Mottaghy Felix M. Mottaghy Felix Manuel Mottaghy
Beziehung	Klinik für Nuklearmedizin (Aachen) (Direktor) (2009-)
Weitere Angaben	seit 12/2008 W3-Professur für Nuklearmedizin an der medizinischen Fakultät der RWTH Aachen; seit 10/2009 Direktor der Klinik für Nuklearmedizin; Promotion 1998 im Fachbereich Humanmedizin; Habilitation 2004 im Fach Nuklearmedizin an der RWTH Aachen Nuklearmediziner geb. in München / Habil.-Schrift Ulm 2004 / Fachgebiet: Nuklearmedizin / Lehrbefugnis erteilt am 23.11.2004
Quelle	Vorlage
Datensatztyp	Person
GND-Nummer	120443686
Datensatz-ID	120443686
Beteiligt an alle anzeigen In Vivo Polymer Mechanochemistry with Polynucleotides Computational Decision Support for PE Diagnosis based on Ventilation Perfusion Ratio Altered biodistribution of [68Ga]Ga-DOTA-TOC during somatostatin analogue treatment EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials Combination of nivolumab with standard induction chemotherapy in children and adults with EBV-positive nasopharyngeal carcinoma : Protocol of a prospective multicenter phase 2 trial Assessment of brain tumour perfusion using early-phase 18F-FET PET: comparison with perfusion-weighted MRI Combination of nivolumab with standard induction chemotherapy in children and adults with EBV-positive nasopharyngeal carcinoma : : Protocol of a prospective multicenter phase 2 trial = Kombination von Nivolumab mit Standard-Induktionschemotherapie bei Kindern und Erwachsenen mit EBV-positivem Nasopharynxkarzinom : Protokoll einer prospektiven multizentrischen Phase-II-Studie In Vivo Polymer Mechanochemistry with Polynucleotides Nonspherical microbubbles for ultrasound-mediated drug delivery Periodontal ligament and alveolar bone remodeling during long orthodontic tooth movement analyzed by a novel user-independent 3D-methodology Assessment of Brain Tumour Perfusion Using Early-Phase 18F-FET PET: Comparison with Perfusion-Weighted MRI How to attract young talent to nuclear medicine step 1: a survey conducted by the EANM Oncology and Theranostics Committee to understand the expectations of the next generation Boosting the acceptance of 18F-FET PET for image-guided treatment planning with a multi-centric prospective trial Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT) Correction: PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer The impact of brain lesions on health-related quality of life in patients with WHO CNS grade 3 or 4 glioma: a lesion-function and resting-state fMRI analysis The influence of receptor expression and clinical subtypes on baseline [18F]FDG uptake in breast cancer: systematic review and meta-analysis PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0 Auger emitter based endogenous therapy with an Olaparib derivative in triple negative breast cancer Boosting the acceptance of 18F-FET PET for image-guided treatment planning with a multi-centric prospective trial Correction : PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer Fetuin-A-based theranostics in ectopic calcification GABAA receptor availability relates to emotion-induced BOLD responses in the medial prefrontal cortex : simultaneous fMRI/PET with [11C]flumazenil How to attract young talent to nuclear medicine step 1 : a survey conducted by the EANM Oncology and Theranostics Committee to understand the expectations of the next generation Hybrid PET/MRI in Cerebral Glioma : Current Status and Perspectives Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT) Neural Stem Cells as Carriers of Nucleoside-Conjugated Nanogels : A New Approach toward Cell-Mediated Delivery Pain Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with 223Ra : PARABO, a Prospective, Noninterventional Study Periodontal ligament and alveolar bone remodeling during long orthodontic tooth movement analyzed by a novel user-independent 3D-methodology Prediction of Primary Tumour and Axillary Lymph Node Response to Neoadjuvant Chemo(Targeted) Therapy with Dedicated Breast [18F]FDG PET/MRI in Breast Cancer PSMA PET/CT : joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0 The impact of brain lesions on health-related quality of life in patients with WHO CNS grade 3 or 4 glioma : a lesion-function and resting-state fMRI analysis The influence of receptor expression and clinical subtypes on baseline [18F]FDG uptake in breast cancer : systematic review and meta-analysis The Potential of PSMA as a Vascular Target in TNBC 99mTc‑labeled single-domain antibody for SPECT/CT assessment of HER2 expression in diverse cancer types Comparison of [99mTc]Tc-tilmanocept with [99mTc]Tc-sulphur colloids and [99mTc]Tc-albumin colloids for sentinel lymph node detection in patients with cutaneous malignancies of the head PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer Radiolabeled Nanocarriers as Theranostics—Advancement from Peptides to Nanocarriers [68 Ga]Ga-FAPI uptake correlates with the state of chronic kidney disease [68 Ga]Ga-FAPI uptake correlates with the state of chronic kidney disease Comparison of [99mTc]Tc-tilmanocept with [99mTc]Tc-sulphur colloids and [99mTc]Tc-albumin colloids for sentinel lymph node detection in patients with cutaneous malignancies of the head PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer Radiolabeled Nanocarriers as Theranostics—Advancement from Peptides to Nanocarriers Hybrid total-body pet scanners—current status and future perspectives 18F-FET-PET-guided gross total resection improves overall survival in patients with WHO grade III/IV glioma: moving towards a multimodal imaging-guided resection 18F-FET-PET-guided gross total resection improves overall survival in patients with WHO grade III/IV glioma : moving towards a multimodal imaging-guided resection 18F-FET-PET-guided gross total resection improves overall survival in patients with WHO grade III/IV glioma: moving towards a multimodal imaging-guided resection Combined 18F-FET PET and diffusion kurtosis MRI in posttreatment glioblastoma: differentiation of true progression from treatment-related changes Combined 18F-FET PET and diffusion kurtosis MRI in posttreatment glioblastoma: differentiation of true progression from treatment-related changes Hybrid total-body pet scanners—current status and future perspectives Sequential implementation of DSC-MR perfusion and dynamic [18F]FET PET allows efficient differentiation of glioma progression from treatment-related changes HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging Advancements in PARP1 targeted nuclear imaging and theranostic probes HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging Sequential implementation of DSC-MR perfusion and dynamic [18F]FET PET allows efficient differentiation of glioma progression from treatment-related changes Sequential implementation of DSC-MR perfusion and dynamic [18F]FET PET allows efficient differentiation of glioma progression from treatment-related changes Short-term discontinuation of vagal nerve stimulation alters 18F-FDG blood pool activity: an exploratory interventional study in epilepsy patients Short-term discontinuation of vagal nerve stimulation alters 18F-FDG blood pool activity : an exploratory interventional study in epilepsy patients Target identification for the diagnosis and intervention of vulnerable atherosclerotic plaques beyond 18F-fluorodeoxyglucose positron emission tomography imaging: promising tracers on the horizon Target identification for the diagnosis and intervention of vulnerable atherosclerotic plaques beyond 18F-fluorodeoxyglucose positron emission tomography imaging: promising tracers on the horizon

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Felix Mottaghy (1970-)

In Vivo Polymer Mechanochemistry with Polynucleotides

Computational Decision Support for PE Diagnosis based on Ventilation Perfusion Ratio

Altered biodistribution of [68Ga]Ga-DOTA-TOC during somatostatin analogue treatment

EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials

Combination of nivolumab with standard induction chemotherapy in children and adults with EBV-positive nasopharyngeal carcinoma : Protocol of a prospective multicenter phase 2 trial

Assessment of brain tumour perfusion using early-phase 18F-FET PET: comparison with perfusion-weighted MRI

In Vivo Polymer Mechanochemistry with Polynucleotides

Nonspherical microbubbles for ultrasound-mediated drug delivery

Periodontal ligament and alveolar bone remodeling during long orthodontic tooth movement analyzed by a novel user-independent 3D-methodology

Assessment of Brain Tumour Perfusion Using Early-Phase 18F-FET PET: Comparison with Perfusion-Weighted MRI

How to attract young talent to nuclear medicine step 1: a survey conducted by the EANM Oncology and Theranostics Committee to understand the expectations of the next generation

Boosting the acceptance of 18F-FET PET for image-guided treatment planning with a multi-centric prospective trial

Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)

Correction: PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer

The impact of brain lesions on health-related quality of life in patients with WHO CNS grade 3 or 4 glioma: a lesion-function and resting-state fMRI analysis

The influence of receptor expression and clinical subtypes on baseline [18F]FDG uptake in breast cancer: systematic review and meta-analysis

PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0

Auger emitter based endogenous therapy with an Olaparib derivative in triple negative breast cancer

Boosting the acceptance of 18F-FET PET for image-guided treatment planning with a multi-centric prospective trial

Correction : PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer

Fetuin-A-based theranostics in ectopic calcification

GABAA receptor availability relates to emotion-induced BOLD responses in the medial prefrontal cortex : simultaneous fMRI/PET with [11C]flumazenil

How to attract young talent to nuclear medicine step 1 : a survey conducted by the EANM Oncology and Theranostics Committee to understand the expectations of the next generation

Hybrid PET/MRI in Cerebral Glioma : Current Status and Perspectives

Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)

Neural Stem Cells as Carriers of Nucleoside-Conjugated Nanogels : A New Approach toward Cell-Mediated Delivery

Pain Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with 223Ra : PARABO, a Prospective, Noninterventional Study

Periodontal ligament and alveolar bone remodeling during long orthodontic tooth movement analyzed by a novel user-independent 3D-methodology

Prediction of Primary Tumour and Axillary Lymph Node Response to Neoadjuvant Chemo(Targeted) Therapy with Dedicated Breast [18F]FDG PET/MRI in Breast Cancer

PSMA PET/CT : joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0

The impact of brain lesions on health-related quality of life in patients with WHO CNS grade 3 or 4 glioma : a lesion-function and resting-state fMRI analysis

The influence of receptor expression and clinical subtypes on baseline [18F]FDG uptake in breast cancer : systematic review and meta-analysis

The Potential of PSMA as a Vascular Target in TNBC

99mTc‑labeled single-domain antibody for SPECT/CT assessment of HER2 expression in diverse cancer types

Comparison of [99mTc]Tc-tilmanocept with [99mTc]Tc-sulphur colloids and [99mTc]Tc-albumin colloids for sentinel lymph node detection in patients with cutaneous malignancies of the head

PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer

Radiolabeled Nanocarriers as Theranostics—Advancement from Peptides to Nanocarriers

[68 Ga]Ga-FAPI uptake correlates with the state of chronic kidney disease

[68 Ga]Ga-FAPI uptake correlates with the state of chronic kidney disease

Comparison of [99mTc]Tc-tilmanocept with [99mTc]Tc-sulphur colloids and [99mTc]Tc-albumin colloids for sentinel lymph node detection in patients with cutaneous malignancies of the head

PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer

Radiolabeled Nanocarriers as Theranostics—Advancement from Peptides to Nanocarriers

Hybrid total-body pet scanners—current status and future perspectives

18F-FET-PET-guided gross total resection improves overall survival in patients with WHO grade III/IV glioma: moving towards a multimodal imaging-guided resection

18F-FET-PET-guided gross total resection improves overall survival in patients with WHO grade III/IV glioma : moving towards a multimodal imaging-guided resection

18F-FET-PET-guided gross total resection improves overall survival in patients with WHO grade III/IV glioma: moving towards a multimodal imaging-guided resection

Combined 18F-FET PET and diffusion kurtosis MRI in posttreatment glioblastoma: differentiation of true progression from treatment-related changes

Combined 18F-FET PET and diffusion kurtosis MRI in posttreatment glioblastoma: differentiation of true progression from treatment-related changes

Hybrid total-body pet scanners—current status and future perspectives

Sequential implementation of DSC-MR perfusion and dynamic [18F]FET PET allows efficient differentiation of glioma progression from treatment-related changes

HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging

Advancements in PARP1 targeted nuclear imaging and theranostic probes

HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging

Sequential implementation of DSC-MR perfusion and dynamic [18F]FET PET allows efficient differentiation of glioma progression from treatment-related changes

Sequential implementation of DSC-MR perfusion and dynamic [18F]FET PET allows efficient differentiation of glioma progression from treatment-related changes

Short-term discontinuation of vagal nerve stimulation alters 18F-FDG blood pool activity: an exploratory interventional study in epilepsy patients

Short-term discontinuation of vagal nerve stimulation alters 18F-FDG blood pool activity : an exploratory interventional study in epilepsy patients

Target identification for the diagnosis and intervention of vulnerable atherosclerotic plaques beyond 18F-fluorodeoxyglucose positron emission tomography imaging: promising tracers on the horizon

Target identification for the diagnosis and intervention of vulnerable atherosclerotic plaques beyond 18F-fluorodeoxyglucose positron emission tomography imaging: promising tracers on the horizon